Understanding Wegovy's Side Effects
Wegovy (semaglutide) is a GLP-1 receptor agonist used for chronic weight management. Side effects are a serious concern for many patients, especially those starting a GLP-1 for the first time. This page draws upon published data, FDA reports, and the experience of clinicians who regularly prescribe Wegovy. For a primer on Wegovy's mechanism and medical uses, see our Wegovy overview.
What Are the Most Common Side Effects?
The most reported side effects of Wegovy relate to the digestive tract. These are a direct result of how GLP-1 medications slow gastric emptying and affect appetite signaling:
- Nausea: Nearly 60% of users report some nausea in the first few weeks, usually mild to moderate.
- Diarrhea: About 30% experience loose stools or urgency, often resolving within a month.
- Constipation: Affects roughly 25% of patients, sometimes longer-term but generally manageable with hydration and fiber.
- Vomiting: Occurs in about 16%, typically within the first dose increases.
- Headache and fatigue: Less common, but noted especially as the dose increases.
Most of these effects are dose-related and tend to decrease as your body acclimates to Wegovy. This is why clinicians recommend a stepwise dose escalation.
How Common Are Serious Side Effects?
While most side effects are mild, some patients experience more significant reactions. According to pivotal trials and post-marketing data:
- Gallbladder disease — About 2% of users develop gallstones or gallbladder inflammation, particularly those with rapid weight loss.
- Pancreatitis — Occurs in approximately 1 in 500 users; symptoms include severe stomach pain and persistent nausea.
- Hypoglycemia — Rare unless combined with insulin or sulfonylureas.
- Kidney injury — Usually secondary to prolonged vomiting/dehydration rather than a direct effect of the medication.
- Injection site reactions — Mild redness or swelling, affecting fewer than 2% of patients.
More severe but extremely rare risks (seen mostly in animal studies) include possible thyroid C-cell tumors. The FDA requires a boxed warning for this, but no confirmed cases have been documented in people using Wegovy for obesity.
Who Should Avoid Wegovy?
Wegovy is not appropriate for everyone. You should not use Wegovy if you:
- Have a personal or family history of medullary thyroid cancer or MEN 2 syndrome
- Are pregnant, trying to conceive, or breastfeeding
- Have had a serious allergic reaction to semaglutide or any component of the injection
- Are under the age of 18
If any of these apply to you, an alternative obesity medication may be safer.
How Can Patients Manage Side Effects?
- Gradual Dose Escalation: Start at the lowest dose and increase according to your provider's timeline. This approach helps your digestive system adapt.
- Small, Frequent Meals: Avoid large, fatty meals which worsen nausea. Stick to bland, easy-to-digest foods.
- Hydration: Drink plenty of water, especially if experiencing vomiting or diarrhea.
- Monitor Symptoms: Track your side effects in a journal. If symptoms worsen or persist, consult your doctor without delay.
- Targeted Symptom Relief: Over-the-counter remedies (with your doctor's approval) can help with nausea or constipation.
Most users find that side effects peak during the first eight weeks, particularly as the dosage increases. For many, these symptoms resolve or become much less intrusive over time.
How Do Wegovy's Side Effects Compare to Other GLP-1s?
Wegovy, like other semaglutide-based medications, shares a similar side effect profile with other GLP-1s. However, compared to older agents, side effects may be slightly less or more intense depending on dose and titration speed. Individual factors—such as preexisting GI disease, dietary habits, and genetics—play a large role.
- GLP-1s as a group tend to cause more GI symptoms than other classes of anti-obesity drugs, but are less likely to cause mood changes or insomnia.
- Weekly injection schedules, as with Wegovy, are generally better tolerated than daily dosing regimens.
Not sure if Wegovy is the right fit? Consider reviewing the full GLP-1 comparison or consult a doctor prescribing obesity therapies for an individualized assessment.
When to Contact a Healthcare Professional
Always reach out to your provider if you experience:
- Severe or persistent nausea, vomiting, or abdominal pain
- Yellowing of the eyes or skin (signs of liver or gallbladder problems)
- Lump or swelling in the neck
- Sudden changes in mood or vision
Catching side effects early makes a major difference in safety and quality of life.
Bottom line: Wegovy's side effects are usually manageable with proper care and education. For most patients, the benefits of sustained weight loss and metabolic improvement outweigh the temporary discomforts—if the medication is used responsibly and monitored by a knowledgeable medical team.